CU Medical (Korea) Performance
| 115480 Stock | KRW 637.00 3.00 0.47% |
The firm owns a Beta (Systematic Risk) of 0.15, which signifies not very significant fluctuations relative to the market. As returns on the market increase, CU Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding CU Medical is expected to be smaller as well. At this point, CU Medical Systems has a negative expected return of -0.15%. Please make sure to confirm CU Medical's coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if CU Medical Systems performance from the past will be repeated sooner or later.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days CU Medical Systems has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
| Total Cashflows From Investing Activities | -1.5 B |
115480 |
CU Medical Relative Risk vs. Return Landscape
If you would invest 70,500 in CU Medical Systems on August 28, 2024 and sell it today you would lose (6,500) from holding CU Medical Systems or give up 9.22% of portfolio value over 90 days. CU Medical Systems is generating negative expected returns and assumes 2.0162% volatility on return distribution over the 90 days horizon. Simply put, 17% of stocks are less volatile than 115480, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
CU Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CU Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CU Medical Systems, and traders can use it to determine the average amount a CU Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0727
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 115480 |
Estimated Market Risk
| 2.02 actual daily | 17 83% of assets are more volatile |
Expected Return
| -0.15 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CU Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CU Medical by adding CU Medical to a well-diversified portfolio.
CU Medical Fundamentals Growth
115480 Stock prices reflect investors' perceptions of the future prospects and financial health of CU Medical, and CU Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on 115480 Stock performance.
| Return On Equity | -4.79 | |||
| Return On Asset | -0.0377 | |||
| Profit Margin | (0.65) % | |||
| Operating Margin | (0.23) % | |||
| Current Valuation | 60.56 B | |||
| Shares Outstanding | 15.89 M | |||
| Price To Sales | 0.50 X | |||
| Revenue | 35.4 B | |||
| EBITDA | (4.81 B) | |||
| Cash And Equivalents | 11.84 B | |||
| Cash Per Share | 135.71 X | |||
| Total Debt | 4.87 B | |||
| Debt To Equity | 0.58 % | |||
| Cash Flow From Operations | 125.22 M | |||
| Total Asset | 72.84 B | |||
About CU Medical Performance
By analyzing CU Medical's fundamental ratios, stakeholders can gain valuable insights into CU Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CU Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CU Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
CU Medical Systems, Inc. manufactures and sells defibrillators worldwide. The company was founded in 2001 and is headquartered in Wonju-si, South Korea. CU MEDICAL is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about CU Medical Systems performance evaluation
Checking the ongoing alerts about CU Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CU Medical Systems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CU Medical Systems generated a negative expected return over the last 90 days | |
| The company reported the revenue of 35.4 B. Net Loss for the year was (14.14 B) with profit before overhead, payroll, taxes, and interest of 12.39 B. |
- Analyzing CU Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CU Medical's stock is overvalued or undervalued compared to its peers.
- Examining CU Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CU Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CU Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CU Medical's stock. These opinions can provide insight into CU Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for 115480 Stock analysis
When running CU Medical's price analysis, check to measure CU Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CU Medical is operating at the current time. Most of CU Medical's value examination focuses on studying past and present price action to predict the probability of CU Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CU Medical's price. Additionally, you may evaluate how the addition of CU Medical to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| CEOs Directory Screen CEOs from public companies around the world |